NCT04466982View on ClinicalTrials.gov

Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

July 2, 2020

Primary Completion Date

December 30, 2022

Study Completion Date

March 30, 2023

Conditions
Olfactory DisorderCOVID19SARS-CoV-2AnosmiaMicrosomiaSmell DisorderQuality of Life
Trial Locations (3)

CB2 0QQ

Addenbrookes Hospital, Cambridge

W6 8RF

Charing Cross Hospital, London

TR1 3LQ

Royal Cornwall Hospital, Truro

All Listed Sponsors
collaborator

Imperial College Healthcare NHS Trust

OTHER

collaborator

Royal Cornwall Hospitals Trust

OTHER

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER

NCT04466982 - Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection | Biotech Hunter | Biotech Hunter